The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002JONES, Mark E; BLOSSER-MIDDLETON, Renée S; THORNSBERRY, Clyde et al.Diagnostic microbiology and infectious disease. 2003, Vol 47, Num 4, pp 579-586, issn 0732-8893, 8 p.Article

In vitro antimicrobial activity of doripenem, a new carbapenemYIGONG GE; WIKLER, Matthew A; SAHM, Daniel F et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1384-1396, issn 0066-4804, 13 p.Article

Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strainKARLOWSKY, James A; CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 3, pp 1063-1066, issn 0095-1137Article

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S; JONES, Mark E et al.International journal of antimicrobial agents. 2002, Vol 20, Num 2, pp 100-107, issn 0924-8579, 8 p.Article

In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVJONES, Mark E; CRITCHLEY, Ian A; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1651-1657, issn 0066-4804Article

The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000JONES, Mark E; BLOSSER-MIDDLETON, Renee S; CRITCHLEY, Ian A et al.Chemotherapy (Basel). 2002, Vol 48, Num 5, pp 232-237, issn 0009-3157, 6 p.Article